Table 1.
Summary of the immunoreactive staining of PELP1 in breast tumors
No staining
Positive staining
Nuclear staining
Cytoplasmic staining
Nuclear and cytoplasmic staining
38.7% (24 of 62)
61.3% (38 of 62)
2.63% (1 of 38)
57.8% (22 of 38)
39.5% (15 of 38)